CAR Natural Killer Cell Therapy Shows Promise in B-Cell Lymphomas

(MedPage Today) -- An investigational induced pluripotent stem cell-derived CAR natural killer cell therapy was well tolerated both as monotherapy and in combination with rituximab among patients with B-cell lymphomas, according to results from...